Continuous surface and air decontamination technologies: Current concepts and controversies - 26/10/23

Abstract |
Effective and safe continuous surface and air decontamination technologies could be a useful adjunct to routine cleaning and disinfection in health care settings. Continuously active quaternary ammonium disinfectants that provide residual antimicrobial activity on undisturbed surfaces for up to 24.ßhours have been shown to reduce the recovery of clinically important pathogens in some but not all real-world studies. Although quaternary ammonium-based supplemental coatings have been reported to provide prolonged residual efficacy in patient care settings, there is concern that some of these products may be removed by routine cleaning and disinfection. To address this concern, the Environmental Protection Agency has recently issued updated guidance requiring demonstration of efficacy after multiple abrasion and chemical exposures for registration of supplemental residual antimicrobial coatings. Far-ultraviolet-C and direct irradiation below exposure limits are promising technologies for continuous air and surface decontamination in occupied spaces, but additional studies are needed to evaluate their long-term safety and efficacy. Given the increasing use of electronic air cleaning technologies in community and health care settings, there is a need for studies to assess real-world efficacy and safety.
El texto completo de este artículo está disponible en PDF.Highlights |
... | Continuous surface and air decontamination could be a useful adjunct to routine cleaning. |
... | Quaternary ammonium disinfectants with residual activity may reduce recontamination. |
... | Far-ultraviolet-C light is promising for continuous air and surface decontamination. |
... | Electronic air cleaning technologies require real-world assessments of safety and efficacy. |
Key Words : Electronic air cleaner, Quaternary ammonium compound
Esquema
| Funding/support: This work was supported by the Department of Veterans Affairs. |
|
| Conflicts of interest: C.J.D. has received research grants to his institution from Clorox, Pfizer, and Ecolab. This article was published as part of a supplement supported by STERIS Corporation, Advanced Sterilization Products, Inc., GOJO Industries, Inc., and IDEATE Medical, Inc. The opinions or views expressed in this article are those of the authors and do not necessarily represent the official position of the funders. |
Vol 51 - N° 11S
P. A144-A150 - novembre 2023 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
